Establishing Normative Values for Thermal Detection and Pain Threshold Established by the Psi Method
NCT ID: NCT04611048
Last Updated: 2021-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
80 participants
INTERVENTIONAL
2020-10-10
2023-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantification of Nerve Stiffness in Neuropathies
NCT03397303
Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy
NCT06514846
The Effect of Hand and Foot Exercises Combined With Cold Application or Virtual Reality on Diabetic Neuropathy
NCT07085130
Impact Of Sensory Re-Education Paradigm On Sensation And Quality Of Life In Patients Post-Covid 19 Polyneuropathy
NCT05911113
Effect of Different Ultrasound Doses on Median Nerve Conduction Parameters
NCT05233488
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Thermal detection threshold evaluation can be used to quantify the extent of function loss (hypoesthesia) and, to a lesser extent, gain (hyperesthesia) in patients with thermonociceptive impairments. They are important features of quantitative sensory testing (QST) protocols (Rolke, Baron, et al., 2006; Rolke, Magerl, et al., 2006) and are pivotal to the determination of sensory phenotypes (Baron et al., 2017; Raputova et al., 2017). Their role is particularly important in the diagnostic workup of neuropathies affecting small fibers (i.e., the subgroup of primary afferents responsible for thermonociception and autonomic functions) such as painful diabetic neuropathies (Terkelsen et al., 2017; Tesfaye et al., 2010).
Currently, clinical measurements of thermal detection thresholds are mainly performed using the method of limits (Fruhstorfer, Lindblom, \& Schmidt, 1976), in which a continuous heating or cooling ramp (usually at a slow rate, 1°C/s in the case of the DFNS QST protocol (Rolke, Magerl, et al., 2006)) is applied to the skin of the patient who is instructed to press a button as soon as he/she feels a warm or cold sensation. The detection threshold is then considered to be the temperature reached at the moment the patient pressed the button. The method of limits has been known for a long time to be methodologically biased due to its reliance on the reaction time (Yarnitsky \& Ochoa, 1991), which lead to an overestimation of the threshold value corresponding to the temperature change that occurred between detection and it's signalling by a motor response. This is problematic as reaction times are under the influence of decision and motor reaction response speeds which may be affected by factors irrelevant to the assessment of sensory discrimination, such as cognitive or motor impairments.
A methodologically sounder approach for threshold measurement is the method of levels or constant stimuli (Kingdom \& Prins, 2010). A number of preselected stimulus intensities are presented a number of times in random order and the subject is asked whether he/she felt each stimulus. Unlike the method of limits, this approach is not biased by decision speed and motor function. Furthermore, this method enables the fitting of a psychometric function (probability of detection as a function of stimulus intensity) to the results, therefore moving thermal detection performance assessments from the outdated High Threshold Theory framework to that of the currently leading Signal Detection Theory (Kingdom \& Prins, 2010). Whereas High Threshold Theory conceptualized detection as an ON/OFF process (below threshold, no detection occurs, above threshold detection always occurs), Signal Detection Theory sees detection as a probabilistic process (each stimulus intensity is associated with a probability of detection). This theoretical framework implies to redefine the threshold as the stimulus intensity for which detection probability equates 0.5. In addition to the threshold, the psychometric function is also defined by its slope, i.e. the rate at which detection probability changes around the value of the threshold. . Unfortunately, the method of levels has some important drawbacks. First, it is time consuming as it requires collecting responses to a large amount of stimuli (usually several hundreds) (Gescheider, 1997). Second, the range of stimulus intensities must be approximately centered on the actual threshold value and cover the transition range of detection probability.
To overcome these limitations, several adaptive procedures have been proposed. These procedures actively adjust the intensity of the presented stimuli depending on the previous responses of the subject (Kingdom \& Prins, 2010). In the present study, we implemented for the first time the Psi method (a Bayesian adaptive algorithm proposed by Kontsevich and Tyler (1999)) to estimate the thresholds and slopes of the psychometric function for heat and cold detection. This algorithm associates each potential values of slope and threshold with a probability, updates this probability distribution based on the response recorded after each stimulus presentation (detected/not detected), and selects the next stimulus intensity so that the response to its presentation maximizes the entropy (i.e. the uncertainty around the values of slope and threshold) reduction.
In this study, we will test healthy controls with the conventional method of limit and the new psi method, in order to establish normative values for the new test.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Main study
Several electrophysiological and behavioural tests will be performed to properly diagnose the patients/check that the healthy controls do not suffer of neuropathy.
Thermal QST (CDT, WDT, CPT, HPT) with the method of limits
The testing will be carried out using the classical method of limits, i.e. a continuous heating/cooling stimulus will be applied to the skin at a rate of 1°C/s, until the subject signals that he/she felt the targeted sensation by pressing a button (Rolke, Baron, et al., 2006). The temperature reached by the time the subject pressed the button will be considered the threshold. Baseline temperature will be set at 32°C. The stimuli will not go lower than 0°C and higher than 50°C.
Thermal QST (cold and warm detection, heat pain) with the psi method
The Psi algorithm is a method using Bayesian statistics to determine not only the threshold but also the slope of the psychometric function (relationship between the intensity of a stimulus and its detection probability; Kingdom \& Prins, 2010). The algorithm selects the next stimulus intensity to be the most informative on the parameters of interest, based on the prior probability density. After each stimulation, the subject will be asked if he/she felt it (as painful) or not. Based on that answer, a posterior probability density is computed. This posterior is then used as prior for the next stimulation. The stimuli will last maximum 1 s and temperature will be kept between 0°C and 60°C.
Neurological examination
A standardized neurological examination will be performed to assess all the items included in the Utah Early Neuropathy Scale (UENS ) (Singleton et al., 2008) and the Toronto Clinical Neuropathy Score (TCNS)(Perkins, Olaleye, Zinman, \& Bril, 2001). This will include: questions about symptoms (presence or absence of foot pain, numbness, tingling, weakness, imbalance and upper limb symptoms); evaluation of knees and ankles deep tendon reflexes; evaluation of pinprick, temperature, light touch, vibration (128 Hz tuning fork) compared to that of an unaffected sites (e.g., sternum); position sensation in the big toes; mapping of pinprick sensitivity in the lower leg; and evaluation of the active extension of the big toes. Pinprick evaluation will be performed using a disposable pin designed for that purpose (Medipin, The United-Kingdom).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thermal QST (CDT, WDT, CPT, HPT) with the method of limits
The testing will be carried out using the classical method of limits, i.e. a continuous heating/cooling stimulus will be applied to the skin at a rate of 1°C/s, until the subject signals that he/she felt the targeted sensation by pressing a button (Rolke, Baron, et al., 2006). The temperature reached by the time the subject pressed the button will be considered the threshold. Baseline temperature will be set at 32°C. The stimuli will not go lower than 0°C and higher than 50°C.
Thermal QST (cold and warm detection, heat pain) with the psi method
The Psi algorithm is a method using Bayesian statistics to determine not only the threshold but also the slope of the psychometric function (relationship between the intensity of a stimulus and its detection probability; Kingdom \& Prins, 2010). The algorithm selects the next stimulus intensity to be the most informative on the parameters of interest, based on the prior probability density. After each stimulation, the subject will be asked if he/she felt it (as painful) or not. Based on that answer, a posterior probability density is computed. This posterior is then used as prior for the next stimulation. The stimuli will last maximum 1 s and temperature will be kept between 0°C and 60°C.
Neurological examination
A standardized neurological examination will be performed to assess all the items included in the Utah Early Neuropathy Scale (UENS ) (Singleton et al., 2008) and the Toronto Clinical Neuropathy Score (TCNS)(Perkins, Olaleye, Zinman, \& Bril, 2001). This will include: questions about symptoms (presence or absence of foot pain, numbness, tingling, weakness, imbalance and upper limb symptoms); evaluation of knees and ankles deep tendon reflexes; evaluation of pinprick, temperature, light touch, vibration (128 Hz tuning fork) compared to that of an unaffected sites (e.g., sternum); position sensation in the big toes; mapping of pinprick sensitivity in the lower leg; and evaluation of the active extension of the big toes. Pinprick evaluation will be performed using a disposable pin designed for that purpose (Medipin, The United-Kingdom).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Habitual substance abuse
* History of chemotherapy
* Scar or dermatological condition at the site of stimulation (forearm and hands, leg and foot)
* History of neurological, psychiatric or metabolic disorder other than Diabetes Mellitus (screening will be performed with the patient)
* Currently taking drugs that could induce neuropathy (screening will be performed with the patient)
* For healthy controls: Suffering of chronic pain
40 Years
79 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER
Université Catholique de Louvain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
André Mouraux, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Université Catholique de Louvain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Neuroscience
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PsiNorm
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.